Results 21 to 30 of about 486,849 (236)
Talc pleurodesis for malignant pleural effusion: efficacy and factors predicting recurrence [PDF]
, 2014 Objectives: To identify potential factors predicting recurrence after talc pleurodesis for malignant pleural effusion. Methods: Retrospective study of two cohorts of consecutive patients undergoing surgery for malignant pleural effusion (T VATS/talc ...
Getzki ,T +7 more
core +1 more source
Recurrence of malignant melanoma presenting as black-colored pyopneumothorax: a rare entity
Annals of Saudi Medicine, 2017 We report a 63-year-old patient with black-colored pus (pyopneumothorax) resulting from an infected pleural effusion associated with metastatic malignant melanoma of the skin.
Ganesh Patel +4 more
doaj +1 more source
Value of Detection of CAIX in the Pleural Effusion and Its Sediment in the Diagnosis of Lung Cancer
Chinese Journal of Lung Cancer, 2015 Background and objective Carbonic anhydrase IX (CAIX) is widely expressed in a variety of malignant tumors, including-lung cancer. Our previous study has shown that the serum level of soluble form of carbonic anhydrase IX (s-CAIX) was significantly ...
Lina PENG +4 more
doaj +1 more source
Clinics, 2014 OBJECTIVES: Our previous study demonstrated that superoxide dismutase levels were higher in tuberculous pleural effusions than in malignant pleural effusions, but that this difference ...
Maoshui Wang +2 more
doaj +1 more source
New biomarkers for the diagnosis of pleural effusion
The Egyptian Journal of Bronchology, 2022 Background Persistent undiagnosed effusion is present in approximately 15% of all causes of exudative effusion. Pleural effusion caused by immunoglobulin G4 (IgG4) is a new type of pleural effusion.
Raafat T. El-Sokkary +3 more
doaj +1 more source
Surgical treatment in malignant pleural effusion
, 2021 Malignant pleural effusion can be described as the presence of exudate in the pleural space, accompanied by the detection of cancer cells in pleural fluid or tissue, which is the indicator of the disease in its advance stages, and survival time of these ...
Sahin, Ekber, Karadayi, Sule
core +1 more source
Tumor associated antigens in diagnosis of serous effusions [PDF]
, 1988 The use of tumour associated antigens in the diagnosis of serous effusions was studied in 76 patients with benign and 200 patients with malignant disease.
Permanetter, W. +4 more
core +1 more source
Case Reports in Oncology, 2021 Malignant pleural effusion represents a prognostic negative factor on survival conferring stage IV disease. The median of survival is 5 months and a 5-year survival of about 3%.
Umberto Caterino +8 more
doaj +1 more source
Chinese Medical Journal, 2015 Background: Hydrothorax, as one of the common complications of malignant tumors, still cannot be sensitively detected in clinical practice, thus requiring a sensitive, specific method for diagnosis.
Yan Gu +10 more
doaj +1 more source
Management of pleural effusion secondary to malignant mesothelioma [PDF]
, 2021 Malignant pleural mesothelioma (MPM) is a highly aggressive pleural tumour which has been epidemiologically linked to occupational exposure to asbestos.
Alberto Aiolfi +11 more
core +2 more sources